Osaic Holdings’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $158K | Buy |
4,227
+1,854
| +78% | +$69.4K | ﹤0.01% | 3780 |
|
|
2025
Q1 | $71.6K | Sell |
2,373
-1,613
| -40% | -$48.7K | ﹤0.01% | 4424 |
|
|
2024
Q4 | $99K | Sell |
3,986
-12,386
| -76% | -$308K | ﹤0.01% | 4170 |
|
|
2024
Q3 | $656K | Buy |
16,372
+1,680
| +11% | +$67.3K | ﹤0.01% | 2624 |
|
|
2024
Q2 | $700K | Buy |
14,692
+66
| +0.5% | +$3.15K | ﹤0.01% | 2481 |
|
|
2024
Q1 | $634K | Sell |
14,626
-4,284
| -23% | -$186K | ﹤0.01% | 2748 |
|
|
2023
Q4 | $956K | Buy |
18,910
+7,462
| +65% | +$377K | ﹤0.01% | 2564 |
|
|
2023
Q3 | $519K | Buy |
11,448
+2,687
| +31% | +$122K | ﹤0.01% | 3210 |
|
|
2023
Q2 | $360K | Sell |
8,761
-774
| -8% | -$31.8K | ﹤0.01% | 3433 |
|
|
2023
Q1 | $341K | Sell |
9,535
-1,294
| -12% | -$46.3K | ﹤0.01% | 3435 |
|
|
2022
Q4 | $408K | Sell |
10,829
-706
| -6% | -$26.6K | ﹤0.01% | 3211 |
|
|
2022
Q3 | $510K | Sell |
11,535
-5,889
| -34% | -$260K | ﹤0.01% | 2871 |
|
|
2022
Q2 | $646K | Sell |
17,424
-2,142
| -11% | -$79.4K | ﹤0.01% | 2682 |
|
|
2022
Q1 | $728K | Buy |
19,566
+419
| +2% | +$15.6K | ﹤0.01% | 2865 |
|
|
2021
Q4 | $583K | Buy |
19,147
+706
| +4% | +$21.5K | ﹤0.01% | 2916 |
|
|
2021
Q3 | $619K | Sell |
18,441
-2,462
| -12% | -$82.6K | ﹤0.01% | 2819 |
|
|
2021
Q2 | $833K | Buy |
20,903
+4,937
| +31% | +$197K | ﹤0.01% | 2521 |
|
|
2021
Q1 | $720K | Buy |
15,966
+2,588
| +19% | +$117K | ﹤0.01% | 2513 |
|
|
2020
Q4 | $757K | Buy |
13,378
+794
| +6% | +$44.9K | ﹤0.01% | 2277 |
|
|
2020
Q3 | $595K | Sell |
12,584
-2,097
| -14% | -$99.2K | ﹤0.01% | 2275 |
|
|
2020
Q2 | $867K | Buy |
14,681
+1,104
| +8% | +$65.2K | ﹤0.01% | 1859 |
|
|
2020
Q1 | $643K | Buy |
+13,577
| New | +$643K | ﹤0.01% | 1865 |
|